Evidence-Based Pharmacology

The Masters in Evidence-Based Pharmacology (Evidence-Based Health Care and Pharmacotherapy; Medical Statistics / Biostatistics; Systematic Reviews; Epidemiology) Program is designed to prepare students for a research career in the expanding field of Evidence-Based Medicine (EBM), pharmaceuticals and Cochrane systematic reviews. The Course is primarily based on students’ active participating in research projects. By the end of the Master’s program graduates should be able to design their own PhD research project.

The Program focuses on the methods in clinical research design and analysis. It builds on the multidisciplinary nature of health care, pharmacology and pharmacotherapy, thorough understanding of causes and pathophysiology of diseases, potential and limitations of interventions. This is reflected in the Master’s program.

The logistics of the Course allows students of the Masters program to opt for lab/clinical or desk research, or a combination of both, thus offering many research opportunities.

The ultimate goal of the teaching staff of the Masters in Evidence-Based Health Care Evidence-Based Pharmacology and Pharmacotherapy; Medical Statistics / Biostatistics; Systematic Reviews; Epidemiology)  Course is to implement the program as a challenging, exciting and comprehensive introduction to the fascinating world of Evidence, Medicine and Pharmaceuticals while mastering the tools of biostatistics and epidemiology.

Why choose this course?

• Masters in Evidence-Based Heath Care degree will prepare students for a research career in the expanding field of Evidence-Based Medicine, pharmaceuticals, biostatistics, epidemiology and Cochrane systematic reviews. It will also provide participants with a greater cultural awareness.
• The degree is distinctly multi-disciplinary in nature and aims to equip participants with a framework for improving their own management action.
• The course includes the opportunity to see health care on an international scale by completing a one-week study tour overseas.
• There is also a unique opportunity to complete a research project working on a real health / health care issue.
• You will complete a comprehensive development programme, which includes a short residential team-building course, normally held in the University village.
• You can learn from the Internationally recognised leaders in EBM by attending guest lectures from world experts and leading EBM organisations.
• You'll have the chance to build your skills and knowledge further with extra-curricular activities such as joining Cochrane Community, Cochrane Crowd, volunteering, and becoming a Student for Best Evidence and / or a Student of Universities Allied for Essential Medicine (UAEM).

Career opportunities

Graduates with a degree of Master’s (MSc) in Evidence-Based Health Care (Evidence-Based Pharmacology and Pharmacotherapy; Medical Statistics / Biostatistics; Systematic Reviews; Epidemiology) Program will have the following career opportunities.

• Primary candidates for many PhD programs, either at the Kazan Federal University or internationally. Masters in Evidence-Based Health Care course provides a unique opportunity of creating students’ own PhD projects and contributing to it in advance.
• Our graduates become key specialists in administrative / legal / regulatory / policy affairs, particularly within the profile of health policy and pharmaceutical regulation. Positions linking medical pharmaceutical sciences to pharmaceutical business or policy strategy shall become increasingly available at governmental and semi-governmental institutions such as the health technology assessment and medicines evaluation boards or Ministries of Health, at societal (non-governmental) organizations.
• Careers in education, lecturing and / or research in Evidence-Based field, Cochrane systematic review development.
• Positions in academic and general hospitals / clinics. They would become key specialists in health-care management, drug evaluation boards / formulary committees, clinical research, policymaking, clinical education, management and communications.   
• Positions in research-intensive institutes within pharmaceutical and biotechnology industry growing in Russia and internationally.  They will be able to contribute to drug innovation within research institutes at any of the growing number of pharmaceutical and biotechnology companies or to advise on the rational use of medicines within health care organizations / health departments / health ministries, etc.

Evidence-Based Pharmacology:

• Evidence-Based Health Care and Pharmacotherapy
• Medical Statistics / Biostatistics
• Systematic reviews
• Epidemiology

Core modules

• Philosophy in Life Sciences
• Psychology of leadership: training workshop
• Professional languages: Russian and English (or other foreign language)
• Report and thesis writing
• Basics of Economics and Management sciences 
• Ethics in biomedical research and practice of medicine
• History and methodology of biomedicine
• Computer technologies in biology, medicine and pharmaceuticals. Programming and mathematical modelling

• Bachelor or specialty degree in Life Sciences, Medicine are preferred
• TOEFL iBT (score min 90) or IELTS (score min 6) or any equivalent English language proficiency exam at the Level B2.

Want to improve your English level for admission?

Prepare for the program requirements with English Online by the British Council.

• ✔️ Flexible study schedule
• ✔️ Experienced teachers
• ✔️ Certificate upon completion

📘 Recommended for students with an IELTS level of 6.0 or below.

Enroll in the course

The financing of the Evidence-Based Pharmacology program at Kazan Federal University is designed to provide accessible higher education for both domestic and international students through a combination of state funding, tuition fees, and supplementary funding sources. Typically, the program benefits from the Russian Federation's system of state scholarships and grants, which support talented and disadvantaged students to pursue their studies without financial burden. These scholarships are allocated based on academic performance, social considerations, and special achievements, ensuring that capable students from diverse backgrounds can access the program.

Tuition fees for the Evidence-Based Pharmacology program are set in accordance with the university's regulations and may vary for Russian citizens and international students. The cost for international students is generally higher, reflecting the broader funding sources available for international education. The university offers various payment options, including full payment, installment plans, and scholarships that partially or fully cover tuition costs. These scholarships are competitive and awarded based on academic merit, research achievements, or financial need, providing significant financial support to outstanding students.

Kazan Federal University also encourages students to seek external funding opportunities, including government grants, private foundations, and international research programs that support studies in pharmacology and related biomedical sciences. The university collaborates with medical and research institutions, creating avenues for research grants and sponsorships for students engaged in evidence-based pharmacological research and internships.

Additionally, students can benefit from assistantship positions, research grants, and project-based funding, which not only provide financial support but also valuable practical experience. These funding mechanisms are aimed at fostering academic excellence and advancing research projects within the field of pharmacology, contributing to the overall development of evidence-based medicine practices.

The university’s strategic goal is to ensure that financial barriers do not hinder talented students from pursuing advanced education in pharmacology. Therefore, the institution actively promotes transparency in funding procedures and provides comprehensive counseling to prospective students regarding available financial aid options. By combining state support, university resources, external grants, and personal funding, Kazan Federal University strives to maintain an inclusive and high-quality educational environment for students of the Evidence-Based Pharmacology program.

The Evidence-Based Pharmacology program at Kazan Federal University is a specialized course designed to provide students with comprehensive knowledge and practical skills in the field of pharmacology, emphasizing evidence-based approaches. This program combines fundamental principles of pharmacology with advanced methodologies for evaluating the efficacy, safety, and effectiveness of pharmaceutical agents through rigorous analysis of clinical data and scientific research. Students are trained to critically assess research papers, interpret clinical trial data, and understand the mechanisms of drug action, interactions, and adverse effects. The curriculum integrates theoretical lectures with laboratory work, seminars, and case studies to foster a practical understanding of how evidence-based practices are applied in pharmacology and healthcare settings. The program aims to prepare graduates for careers in pharmaceutical research, clinical pharmacology, healthcare policy, and regulatory affairs by equipping them with skills to analyze and synthesize scientific evidence, design and conduct research studies, and implement best practices in drug therapy. In addition, students learn about the latest developments in pharmacovigilance, personalized medicine, and new drug development processes. The faculty includes leading experts in pharmacology and clinical research, ensuring that students receive high-quality instruction aligned with current scientific standards and industry needs. Participating in this program also offers opportunities for internships and collaborations with research institutes and pharmaceutical companies, fostering practical experience and professional networking. Overall, the Evidence-Based Pharmacology program at Kazan Federal University is dedicated to producing highly qualified specialists capable of contributing to advancements in medicine and healthcare through scientifically grounded decision-making.